Related Experiment Video
Updated: Aug 6, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
UBE2C at the crossroads of cell cycle regulation and DNA damage response in cancer
Sayandrila Paul1, Amoolya Kandettu1, Sanjiban Chakrabarty2
1Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
Abstract:
The ubiquitin-proteasome system (UPS) is an important regulator of numerous cellular pathways, including DNA repair, protein degradation, the cell cycle, and signal transduction. UBE2C, a member of the ubiquitin-conjugating enzyme family, facilitates the ubiquitination of essential cellular regulators. Notably, UBE2C is consistently overexpressed in breast, lung, brain, hepatocellular, and ovarian carcinomas. Increased UBE2C expression is associated with tumour aggressiveness, genomic instability, epithelial-to-mesenchymal transition, and resistance to chemotherapy and radiotherapy. Our review explores the mechanistic involvement of UBE2C in diverse cancers, with a particular focus on its involvement in DNA damage repair mediated by the anaphase-promoting complex (APC/C). Furthermore, the regulatory effects of miR-381, miR-503, and miR-205 on UBE2C expression were examined, highlighting the promising prospects of these miRNAs for targeted cancer therapy. The involvement of UBE2C in different cancer hallmarks underscores its potential as a biomarker and therapeutic target. A comprehensive understanding of its mechanistic involvement in cell cycle regulation and DNA repair will further enhance its application in diagnostics, personalised medicine, and precision medicine.
Insights
The ubiquitin-proteasome system (UPS) enzyme UBE2C is overexpressed in many cancers, driving tumor growth and treatment resistance. Targeting UBE2C and its regulators offers promising new cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The ubiquitin-proteasome system (UPS) regulates critical cellular processes like DNA repair and cell cycle progression.
- UBE2C, a ubiquitin-conjugating enzyme, is crucial for ubiquitylation of key cellular regulators.
- UBE2C overexpression is prevalent in various carcinomas, correlating with aggressive tumor phenotypes and therapeutic resistance.
Purpose of the Study:
- To review the mechanistic role of UBE2C in diverse cancers.
- To highlight UBE2C's involvement in DNA damage repair via the anaphase-promoting complex (APC/C).
- To explore the therapeutic potential of targeting UBE2C and its miRNA regulators (miR-381, miR-503, miR-205).
Main Methods:
- Literature review focusing on UBE2C's function in cancer.
- Analysis of UBE2C's role in DNA repair pathways.
- Examination of miRNA-mediated regulation of UBE2C.
Main Results:
- UBE2C overexpression is linked to tumor aggressiveness, genomic instability, epithelial-to-mesenchymal transition, and resistance to therapies.
- UBE2C plays a significant role in DNA damage repair processes.
- Specific miRNAs (miR-381, miR-503, miR-205) regulate UBE2C expression, suggesting therapeutic avenues.
Conclusions:
- UBE2C is a potential biomarker and therapeutic target in multiple cancer types.
- Understanding UBE2C's role in cell cycle regulation and DNA repair is key for developing novel diagnostics and precision medicine strategies.
- Targeting UBE2C and its miRNA regulators shows promise for innovative cancer treatments.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
Negative Regulator Molecules

